Instrumento Inactivo

Otros idiomas Phase Holographic Imaging PHI AB Swiss Exchange

Acciones

SE0005504636

Precio de cierre Swiss Exchange Otros sitios de cotización
- ^SEK	-

27/03	Phase Holographic Imaging PHI AB (publ) presenta los resultados del tercer trimestre y los nueve meses finalizados el 31 de enero de 2024	CI
14/03	Phase Holographic Imaging PHI AB (Publ) nombra a Ivan Jurkovic miembro ordinario del consejo de administración	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Phase Holographic Imaging Obtains SEK7 Million Loan Agreement	17/05
PHI secures a loan facility of in total SEK 7 million	17/05
PHI announces conference schedule for spring 2024	02/04
Interim Report 3 2023/24	27/03
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	27/03
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)	14/03
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member	14/03
Shaping the future of Regenerative Medicine - PHI's vision for QPI in Cell Therapy Manufacturing	11/03
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine	11/03
New Distributor Partner Manager at Altium set to enhance global sales for PHI	05/03
Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB	26/02
PHI to BioStock: "We aim to revolutionize the regenerative medicine market "	21/02
PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024	07/02
PHI announces extraordinary quarter sales of about 5MSEK - marks the highest ever in Company history	30/01
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024	30/01
Interim Report 2 2023/24	21/12
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	21/12
PHI appoints Pareto Securities AB to act as a liquidity provider for the Company's share	15/12
PHI granted patent on synthetic antibodies in the EU	07/12
Directed issue registered at the Companies Registration Office	23/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Phase Holographic Imaging PHI AB Swiss Exchange

Acciones

SE0005504636

Otros idiomas

Filtros